Skip to main content

Aerie Pharmaceuticals Inc. Common Stock (AERI)

About The Company

AERI Stock Market Logo

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roklatan. The company mainly operates in North America.

IPO Year Sector Industry
2013 Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Aerie Pharmaceuticals Inc. (AERI) Latest News

Company Contact & Address (AERI)

Corporate Headquarters Phone Website
4301 EMPEROR BOULEVARD SUITE 400,
DURHAM,
North Carolina,
27703,
United States
+1 919 237-5300 Official AERI Website

AERI Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Biological Products (No Diagnostic Substances) Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ AERI

Jobs & Employment at Aerie Pharmaceuticals Inc.

LinkedIn Company Page https://www.linkedin.com/company/aerie-pharmaceuticals
Official Career & Employment Page Jobs & Careers at Aerie Pharmaceuticals Inc. (AERI)

Related & Similar Stock Symbols

CDLX Stock Market Price & News

CDLX

Cardlytics Inc. Common Stock

TRQ Stock Market Price & News

TRQ

Turquoise Hill Resources Ltd. Ordinary Shares

NREF^A Stock Market Price & News

NREF^A

NexPoint Real Estate Finance Inc. 8.50% Series A …